Alpha 2.0
Login Register
» Articles » PMID: 35868235

Lighting the Way to Host-directed Immunotherapeutics

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2022 Jul 22
PMID 35868235
Authors
Sarah van Tol
Adam Hage
Ricardo Rajsbaum
Affiliations
Soon will be listed here.
Abstract

Developing broad-spectrum, host-directed antiviral therapeutics can be adapted to combat emerging viruses. In this issue of Cell Chemical Biology, Maarifi and colleagues implement a Nano luciferase reporter-based protein complementation assay to screen for small molecules and identify Gilteritinib, which enhances interferon induction and antagonizes virus replication.

References
1.
Dhillon S . Gilteritinib: First Global Approval. Drugs. 2019; 79(3):331-339. DOI: 10.1007/s40265-019-1062-3. View
2.
Lemke G . Biology of the TAM receptors. Cold Spring Harb Perspect Biol. 2013; 5(11):a009076. PMC: 3809585. DOI: 10.1101/cshperspect.a009076. View
3.
Sharif M, Sosic D, Rothlin C, Kelly E, Lemke G, Olson E . Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med. 2006; 203(8):1891-901. PMC: 2118370. DOI: 10.1084/jem.20051725. View
4.
McNab F, Mayer-Barber K, Sher A, Wack A, OGarra A . Type I interferons in infectious disease. Nat Rev Immunol. 2015; 15(2):87-103. PMC: 7162685. DOI: 10.1038/nri3787. View
5.
Maarifi G, Martin M, Zebboudj A, Boulay A, Nouaux P, Fernandez J . Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses. Cell Chem Biol. 2022; 29(7):1113-1125.e6. PMC: 9213012. DOI: 10.1016/j.chembiol.2022.05.009. View